You are here: Industry Insights > Biopharmaceutical

News List

New biopharmaceutical testing laboratory to open in Geneva cphi-online
August 29, 2018
SGS's expansion will enable the service provider to offer a full ICH Q6B physico-chemical characterization of biological products.
Ligand Pharma readies $650M convertible debt offering biospectrumasia
May 18, 2018
In connection with the offering of the notes, Ligand expects to grant the initial purchasers a 13-day option to purchase up to an additional $100 million aggregate principal amount of the notes, solely to cover overallotments, if any.
Sinovac Amends Shareholder Rights Plan prnasia
March 07, 2018
Sinovac Biotech Ltd. today announced that its board of directors has amended its shareholder rights plan. The amendment extends the expiration date of the plan from March 27, 2018 to March 27, 2019.
With a Collaboration Deal in Place with Merck, Cue Biopharma Plans $60 Million IPO biospace
December 20, 2017
Cue BioPharma is on a roll, having recently signed a deal with Merck and is planning an initial public offering (IPO) to raise up to $60 million.
8 Possible Biopharma Takeover Targets for 2018 biospace
December 19, 2017
Many investors and analysts expect 2018 to be a big deal for mergers and acquisitions. The proposed tax plan not only reduced corporate income tax to about 21%, but also proposed a one-time amnesty of 10% for overseas funds to be repatriated.
RedHill Biopharma announces successful Phase III pharmaasia
July 04, 2017
RedHill Biopharma announces successful Phase III top-line results with BEKINDA for Acute Gastroenteritis.
Personalised medicine, batch size of ONE, the new challenge to fill-finish? contractpharma
June 30, 2017
Wenzel Novak PhD gives some considerations on container, environment, process and automation for small batch sizes in the downstream process of fill-finish…
Active Dashboard 2 Allows Easy Access to Process Performance Data b3cnewswire
June 27, 2017
Advanced software solution ensures superior manufacturing quality and enables effective decision-making
Zytoprotec's Novel Dialysis Product Meets Both Endpoints in Phase II Study b3cnewswire
June 13, 2017
Zytoprotec announced today the highly promising outcome of the Phase II study of its peritoneal dialysis fluid PD-protec®.
Sartorius Stedim Biotech Partners with Nova Biomedical b3cnewswire
May 18, 2017
Firms combine ambr® technology with the BioProfile® FLEX2;Unique tool will allow massive quantities of cell culture data to be collected during upstream processing QbD studies.

Previous page 1 2 3 4 5 6 7 Next page